MorphoSys is a commercial-stage biopharmaceutical company dedicated to the discovery, development, and delivery of innovative cancer medicines. Our ambition is to redefine how cancer is treated. As a commercial-stage biopharmaceutical company, we are driven by the urgency to deliver groundbreaking medicines, aspiring to give more life for people with cancer. Our values guide us in the decisions we make each day. They shape our commitment to one another and society – underscoring our collective responsibility to operate with the highest level of integrity, respect and quality standards. We are conscious of the responsibility we share for present and future generations and weigh all our actions in terms of their impact on the environment, society, patients and employees. Advancing science is at our core, but even more so is our dedication to make a difference for patients.